Related Experiment Video

Updated: May 6, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research

Raffaella Mistrulli1,2, Armando Ferrera1, Luigi Salerno1

  • 1Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Biomedicines
|July 27, 2024
PubMed

Insights

Preventing sudden cardiac death (SCD) in cardiomyopathies is complex, especially in young people. Integrating clinical, genetic, and advanced imaging like cardiac magnetic resonance (CMR) improves risk assessment and patient survival.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Sudden cardiac death (SCD) prevention in cardiomyopathies (hypertrophic, dilated, non-dilated left ventricular, arrhythmogenic right ventricular) is a significant clinical challenge, particularly in younger individuals.
  • Risk stratification is complicated by variable disease presentation and genetic diversity within these conditions.

Purpose of the Study:

  • To explore comprehensive strategies for SCD prevention across various cardiomyopathies.
  • To highlight the importance of integrating clinical evaluation, genetic data, and advanced imaging for risk assessment.

Main Methods:

  • Review of current clinical practices and research findings.
  • Emphasis on the role of advanced imaging techniques, specifically cardiac magnetic resonance (CMR).
  • Discussion of genetic insights in understanding disease heterogeneity.

Main Results:

  • Cardiac magnetic resonance (CMR) enhances understanding of myocardial structure and aids in identifying high-risk patients.
  • Multifaceted strategies combining clinical, genetic, and imaging data are crucial for effective SCD risk stratification.

Conclusions:

  • Integration of advanced imaging and genetic insights with clinical assessment is vital for improving SCD risk prediction in cardiomyopathies.
  • Further research is needed to refine risk stratification models and enhance the predictive power of clinical and imaging techniques for better patient outcomes.

Keywords:
cardiomyopathiescardiovascular preventionrisk stratificationsudden cardiac death

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

6.9K
Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

2.5K

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762